[SVNS] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[SVNS] Solvonis Therapeutics plc
Announcement Date
30-Dec-2022
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -131.90%
YoY- -53.91%
Quarter Report
SVNS's Result
SVNS's Financial Summary
View:
Show?
Quarter Result
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 CAGR
Revenue 0 347 211 149 486 -
PBT -349 -1,994 -1,890 -1,228 -84 42.73%
Tax 0 0 0 0 -0 -
NP -335 -1,994 -1,890 -1,228 -84 41.28%
Tax Rate - - - - - -
Total Cost 335 2,341 2,101 1,378 570 -12.43%
Ratio Analysis
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 CAGR
NP Margin 0.00 -574.64 -895.73 -822.08 -17.35 -
Per Share
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 CAGR
EPS -0.00 -0.02 -0.02 -0.01 -0.00 -
EPS Diluted -0.00 -0.02 -0.02 -0.01 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.